Article
Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?
Current drug targets - 1 Jan 2015
Heard Ashley, Thompson Jake, Carver Jessica, Bakey Michelle, Wang X Robert
Abstract excerpt
Cystic Fibrosis (CF) is largely caused by protein misfolding and the loss of function of a plasma membrane anion channel known as the cystic fibrosis transmembrane conductance regulator (CFTR). The most common CF-causing mutation, F508del, leads to severe conformational defect in CFTR. The cellular chaperone machinery plays an important role in CFTR biogenesis and quality control. Multiple attempts have been made...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
